@icenipharma.com
Iceni® Pharmaceuticals is a develops cancer therapies, specialising in repurposing and reformulating existing drugs for new indications.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
ICENI Pharma is a leading pharmaceutical company that specializes in developing innovative cancer therapies. Their unique approach involves repurposing and reformulating existing drugs for new indications, reducing costs and risks associated with drug development. This strategy allows for more rapid availability of new treatments, as these drugs have already undergone extensive clinical trials and have well-established safety profiles.
One of ICENI Pharma's flagship products is Cilcane®, a pentapeptide drug that shows great promise in the treatment of multiple myeloma, a type of blood cancer. Unlike existing myeloma treatments, Cilcane® offers a novel mechanism of action. It is designed to be used as a supplementary therapy in combination with other medications, rather than replacing them.
Cilengitide, the generic name for Cilcane®, has previously undergone an extensive Phase III clinical development program for the treatment of brain cancer. Now, many of the same experienced professionals are working with ICENI Pharma to develop Cilcane® for multiple myeloma and breast cancer. With a focus on innovation and safety, ICENI Pharma is dedicated to improving the lives of cancer patients and driving progress in the field of cancer treatment
Company Type
Privately Held
Company Size
11-50
Year Founded
2016
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online